![](/img/cover-not-exists.png)
2864 Defining 131I-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by 131I-refractory criteria in the SELECT trial
Kiyota, N., Robinson, B., Shah, M., Hoff, A.O., Taylor, M., Li, D., Dutcus, C., Lee, E.K., Kim, S.B., Tahara, M.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31602-1
Date:
September, 2015
File:
PDF, 62 KB
english, 2015